Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lapierre

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Treatment of spasticity with tizanidine in multiple sclerosisY Lapierre, S Bouchard, C Tansey, et al.
Biological Psychiatry|November 1, 1982
Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorderB Waters, Y Lapierre, A Gagnon, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1985
Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progressionP Duquette, F Décary, J Pleines, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2005
Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetateN Arbour, E Rastikerdar, E McCrea, et al.
Brain : a Journal of Neurology|November 14, 2002
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disabilityH Reddy, S Narayanan, M Woolrich, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1988
A linkage study of primary affective disorderB Waters, D Sengar, I Marchenko, et al.
Clinical and Experimental Immunology|January 18, 2006
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanismsD A Duszczyszyn, J D Beck, J Antel, et al.
Journal of Neurology|January 18, 2005
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE studyM Sandberg-Wollheim, C Bever, J Carter, et al.
Journal of Neurology|February 27, 2014
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don'tIlana R Leppert, S Narayanan, D Araújo, et al.
AJNR. American Journal of Neuroradiology|July 22, 1998
Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activityI Trop, P M Bourgouin, Y Lapierre, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Treatment of spasticity with tizanidine in multiple sclerosisY Lapierre, S Bouchard, C Tansey, et al.
Biological Psychiatry|November 1, 1982
Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorderB Waters, Y Lapierre, A Gagnon, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1985
Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progressionP Duquette, F Décary, J Pleines, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2005
Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetateN Arbour, E Rastikerdar, E McCrea, et al.
Brain : a Journal of Neurology|November 14, 2002
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disabilityH Reddy, S Narayanan, M Woolrich, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1988
A linkage study of primary affective disorderB Waters, D Sengar, I Marchenko, et al.
Clinical and Experimental Immunology|January 18, 2006
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanismsD A Duszczyszyn, J D Beck, J Antel, et al.
Journal of Neurology|January 18, 2005
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE studyM Sandberg-Wollheim, C Bever, J Carter, et al.
Journal of Neurology|February 27, 2014
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don'tIlana R Leppert, S Narayanan, D Araújo, et al.
AJNR. American Journal of Neuroradiology|July 22, 1998
Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activityI Trop, P M Bourgouin, Y Lapierre, et al.
Pageof 4